This population-based cohort study utilized data from 14,289 adults in NHANES III (1988–1994) with mortality follow-up through 2011 to evaluate the relationship between low blood lead levels and long-term mortality. The analysis revealed that individuals with blood lead levels between 1.0 and 6.7 μg/dL faced significantly higher risks of all-cause
This large-scale prospective study analyzed data from 13,946 adults in the NHANES III cohort (1988–1994) with up to 12 years of follow-up. It found that even blood lead levels below 0.48 μmol/L (10 μg/dL) were associated with increased all-cause and cardiovascular mortality. Participants in the highest tertile of blood lead
This study analyzed data from 3,482 adults in the NHANES III cohort to examine the association between blood lead levels and mortality. Findings indicated that higher blood lead concentrations were significantly associated with increased risks of all-cause mortality (OR 1.05; 95% CI 1.01–1.08), all cancer mortality (OR 1.07; 95% CI
This 2013 cohort study published in the American Journal of Clinical Nutrition analyzed data from 13,504 U.S. adults in NHANES III to examine the relationship between magnesium intake and liver disease mortality over a follow-up period through 2006. The study found that each 100 mg/day increase in magnesium intake was
